Foundation Medicine

Grateful for all those within our communities - our patients, partners, healthcare providers and beyond. Wishing everyone a very happy holiday season!

Through community engagement opportunities, Foundation Medicine employees are able to give back to their local communities through various activities throughout the year. This Fall, some of our Boston-based colleagues took time to support American Cancer Society’s Hope Lodge which offers a home away from home for those facing cancer and their caregivers when cancer treatment is far away. #WeAreFMI

“Over 60% of patients will have at least one of these genomic alterations [AKT1/PIK3CA/PTEN/ESR1] when tested in the first-line setting.” – Dr. Mia Levy, Chief Medical Officer at Foundation Medicine Hear more from Dr. Levy in a new Foundation Frontiers discussion that explores updates to the current treatment landscape for hormone-receptor positive, HER2-negative recurrent, metastatic #BreastCancer and the role of tissue- and blood-based #BiomarkerTesting in guiding treatment decisions. Watch on-demand now: http://spkl.io/6042fwD7j

Collaborations across the oncology landscape help drive further education and access to precision medicines for those with unmet needs. We are proud to announce we have awarded two grants in support of addressing disparities in biomarker testing for breast and prostate cancer: 💡 Living Beyond Breast Cancer and Sidney Kimmel Comprehensive Cancer Center at Jefferson for “No One Missed: Grassroots Pilot for Under-Resourced Metastatic Breast Cancer Patients” 💡 Patient Advocate Foundation and ZERO Prostate Cancer for “A Patient-Focused Partnership to Advance Health Equity in Biomarker Testing among Patients with Prostate Cancer” Click here to read more: http://spkl.io/6045fZ3Zv

We’re looking forward to engaging with breast cancer oncologists, researchers, patients and advocates at the 2024 San Antonio Breast Cancer Symposium®. Stop by booth 1149 to meet with a member of our team and learn about how our portfolio of comprehensive genomic profiling tests can help inform treatment decisions for patients with advanced breast cancer. #SABCS24 Click the link to schedule a meeting with our team during the conference: http://spkl.io/6045fka9W

Foundation Medicine employees came together for a ribbon painting activity in support of The White Ribbon Project and the lung cancer community. Joined by founders Heidi and Pierre Onda, The White Ribbon Project aims to promote awareness by spreading the word that “anyone with lungs can get lung cancer.” Colleagues were able to share some words of encouragement on the ribbons which will be distributed to individuals living with lung cancer. We’re proud to support the organization’s efforts to educate around this disease and are happy to have taken part in making some ribbons. #LungCancerAwareness

Foundation Medicine has delivered over 80,000 reports for patients with hematologic malignancies, delivering insights to improve patient care. With our expertise in companion diagnostic development and the comprehensive FoundationOne®Heme* test, we help identify critical alterations such as translocations and fusions. Learn more by visiting us at booth 2604 or scheduling a meeting with our experts: http://spkl.io/6046fX1wi *LDT; Rx only; advanced cancer; doesn't guarantee treatment match.

Proud to support the lung cancer community this #LungCancerAwarenessMonth and beyond. Happy to help spread education and awareness around the work that ALK Positive Inc. is doing to help further research and better understand of ALK+ lung cancers.

November is a time dedicated to helping spread awareness and education around #MensHealth. From growing mustaches to participating in physical activity and moving for mental health, employees across Foundation Medicine have been participating in #Movember activities in support of this movement to change men’s health. Read through to see how some of our colleagues showed their “Mo.”